| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918438 | Radiotherapy and Oncology | 2014 | 6 Pages |
Abstract
ITACs have been observed in 72% of all lung cancer patients during the course of radical radiotherapy. The clinical relevance of the proposed ITAC classification in lung radiotherapy needs to be validated in a prospective analysis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Margriet Kwint, Sanne Conijn, Eva Schaake, Joost Knegjens, Maddalena Rossi, Peter Remeijer, Jan-Jakob Sonke, Jose Belderbos,